KOD Stock Posts

3/27/2026 12:37:14 PM

Unusual Option Volume

KOD Kodiak Sciences40.93+1.17 (+2.9%)

Kodiak Sciences trades 2,347 contracts.

View Details...

3/26/2026 10:21:18 AM

Unusual Option Volume

KOD Kodiak Sciences33.81+11.06 (+48.6%)

Kodiak Sciences trades 4,647 contracts. News: Kodiak Sciences Announces Positive Topline Results in GLOW2, the Second Phase 3 Study in Diabetic Retinopathy, Demonstrating Superiority of Zenkuda (tarcocimab tedromer) Over Sham

View Details...

12/15/2025 11:54:43 PM

KOD #KodiakSciences stock declines -6.6% in after hours trading. See the latest news.

After Hours Decliner

KOD Kodiak Sciences23.02-0.79-3.3%

After Hours:21.50-1.52 (-6.6%)

Kodiak Sciences Announces Proposed Public Offering of Common Stock

PRNewswireMon, 15-Dec 4:01 PM

9/25/2025 3:51:00 PM

Unusual Option Volume

KOD Kodiak Sciences16.04+0.55 (+3.6%)

Kodiak Sciences trades 2,231 contracts.

View Details...

7/24/2023 10:25:07 AM

Unusual Option Volume

KOD Kodiak Sciences3.56-3.73 (-51.2%)

Kodiak Sciences trades 2,818 contracts. News: Kodiak Sciences Announces Topline Results from its Phase 3 Studies of Tarcocimab Tedromer in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema and Provides Update on Tarcocimab Development Program

View Details...

7/24/2023 8:26:01 AM

KOD #KodiakSciences stock declines -46.9% in premarket,

Premarket Decliner

KOD Kodiak Sciences7.29+0.21+3.0%

Premarket:3.87-3.42 (-46.9%)

Kodiak Sciences Announces Topline Results from its Phase 3 Studies of Tarcocimab Tedromer in Neovascular Age-Related Macular Degeneration and Diabetic Macular Edema and Provides Update on Tarcocimab Development Program

PRNewswireMon, 24-Jul 6:00 AM

Load Earlier Posts

Market Data Delayed 15 Minutes

Questions? Feedback?Olark live chat software